Who wins, who loses with biogenerics

Who wins, who loses if and when generic biotech drugs, also known as biogenerics, are finally allowed on the U.S. market?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.